AURELIUS EQUITY OPPORTUNITIES SE & CO. KGAA

(AR4)
  Report
Delayed Xetra  -  11:36 2022-08-18 am EDT
23.96 EUR   +1.01%
08/16AURELIUS sells operating business of Transform Hospital Group to Y1 Capital
EQ
08/15AURELIUS EQUITY OPPORTUNITIES SE & CO. KGAA : Release of a capital market information
EQ
08/11AURELIUS Equity Opportunities SE & Co. KGaA Reports Earnings Results for the Half Year Ended June 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

AURELIUS European Opportunities IV managed by AURELIUS Equity Opportunities SE & Co. KGaA agreed to acquire Dental Bauer GmbH & Co. KG and Pluradent GmbH & Co. KG from Linneweh family and Pluradent from self-administration.

06/20/2022 EDT

AURELIUS European Opportunities IV managed by AURELIUS Equity Opportunities SE & Co. KGaA (XTRA:AR4) and Linneweh family agreed to acquire Dental Bauer GmbH & Co. KG and Pluradent GmbH & Co. KG from Linneweh family and others on June 20, 2022. As part of the transaction, Linneweh family is reinvesting. Deal is subject to approval by the relevant competition and regulatory authorities. The transaction is expected to close in Q3 2022. LBBW Equity Partners GmbH & Co. KG acted as financial advisor while Haver & Mailander acted as legal advisor to AURELIUS. AURELIUS was advised on the transactions by Roland Berger (Commercial), OMMAX (Digital), Accuracy (Financial), Oppenhoff (Tax), Intargia (IT), EURO Transaction Solutions (Insurance). OMMAX GmbH acted as financial advisor to AURELIUS. Marlies Raschke, Dominik Rompza, Christian C.-W. Pleister, Moritz Nikolaus Koch, Dorothee Prosteder, Stefan Schwab, Isabel Jakobs, Pascal Schumacher, Sebastian Dienst, Patrick Neidinger, Peter Stauber, Ludomir Biedecki, Justyna Ciepla of Noerr Partnerschaftsgesellschaft mbB acted as legal advisor to AURELIUS Equity Opportunities SE & Co. KGaA.


© S&P Capital IQ 2022
All news about AURELIUS EQUITY OPPORTUNITIES SE & CO. KGAA
08/16AURELIUS sells operating business of Transform Hospital Group to Y1 Capital
EQ
08/15AURELIUS EQUITY OPPORTUNITIES SE & C : Release of a capital market information
EQ
08/11AURELIUS Equity Opportunities SE & Co. KGaA Reports Earnings Results for the Half Year ..
CI
08/11TRANSCRIPT : AURELIUS Equity Opportunities SE & Co. KGaA, H1 2022 Earnings Call, Aug 11, 2..
CI
08/11AURELIUS Equity Opportunities reports robust growth also in the first half of 2022 desp..
EQ
08/08AURELIUS EQUITY OPPORTUNITIES SE & C : Release of a capital market information
EQ
08/08AURELIUS EQUITY OPPORTUNITIES : closes the acquisition of Footasylum from JD Sports
PU
08/08JD Sports Fashion Closes $45 Million Footasylum Sale After UK Watchdog Order
MT
08/05AURELIUS EUROPEAN OPPORTUNITIES IV, : Jd.).
CI
08/02AURELIUS EQUITY OPPORTUNITIES : successfully closes the sale of portfolio company Hammerl ..
PU
More news
Analyst Recommendations on AURELIUS EQUITY OPPORTUNITIES SE & CO. KGAA
More recommendations
Financials
Sales 2022 2 867 M 2 907 M 2 907 M
Net income 2022 52,0 M 52,7 M 52,7 M
Net Debt 2022 239 M 242 M 242 M
P/E ratio 2022 20,3x
Yield 2022 6,26%
Capitalization 655 M 664 M 664 M
EV / Sales 2022 0,31x
EV / Sales 2023 0,31x
Nbr of Employees 11 057
Free-Float 89,2%
Chart AURELIUS EQUITY OPPORTUNITIES SE & CO. KGAA
Duration : Period :
AURELIUS Equity Opportunities SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AURELIUS EQUITY OPPORTUNITIES SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 23,96 €
Average target price 43,78 €
Spread / Average Target 82,7%
EPS Revisions
Managers and Directors
Dirk Markus Chairman-Executive Board
Matthias Täubl Chief Executive Officer
Richard Schulze-Muth Chief Financial Officer
Christian Dreyer Chairman-Supervisory Board
Frank Forster Chief Compliance Officer & General Counsel
Sector and Competitors